Position in EPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,041,354
-$1,026,646 QoQ
Shares Held
611,400
-12.7% QoQ
Ownership
0.925%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#14
of 68 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Redmile Group, LLC holds $1,454,356,867 across 35 Biotechnology names. EPRX ranks #31 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
4,311,092 | $237,110,060 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
632,005 | $234,897,298 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
3,945,920 | $129,110,502 | |
| 4 | IMNM |
Immunome Inc.
|
4,911,590 | $104,076,592 | |
| 5 | NRIX |
Nurix Therapeutics, Inc.
|
4,073,787 | $98,830,072 | |
| 6 | ABSI |
Absci Corp
|
6,739,675 | $78,112,833 | |
| 7 | ANNX |
Annexon, Inc.
|
11,869,877 | $67,776,997 | |
| 8 | RGNX |
REGENXBIO Inc.
|
4,368,804 | $52,338,271 |
All Filings in EPRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,041,354 | 611,400 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,068,000 | 700,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||